Financials
- Market Capitalization 238.75 M
- Employee 122
- Founded 2020
- CEO N/A
- Website www.invivyd.com
- Headquarter Delaware, United States
- FIGI BBG00W4ML039
- Industry 生物技术
总收入
净利润
每股基本收益(基本 EPS)
总债务
自由现金流
现金及现金等价物
市盈率
-2.81
市销率
3.28
Related tickers
| # | 姓名 | 价格 | 24小时 % | 7天 % | 一个月 % | 一年 % | 市值 | 最近7天 | |
|---|---|---|---|---|---|---|---|---|---|
| 3487 | CLLS Cellectis S.A. - American Depositary Shares | 3.32 USD | +0.61% | -2.92% | +16.08% | +29.18% | 238.21 M USD | ||
| 3489 | RNA Atrium Therapeutics, Inc. - Common Stock | 14.06 USD | +2.11% | +1.52% | +22.79% | -80.01% | 240.51 M USD | ||
| 3507 | TNXP Tonix Pharmaceuticals Holding Corp. - Common Stock | 13.37 USD | -4.36% | -1.98% | +31.59% | -10.93% | 229.31 M USD | ||
| 3509 | TARA Protara Therapeutics, Inc. - Common Stock | 3.95 USD | +1.28% | +1.02% | +0.25% | +24.61% | 233.43 M USD |